×
Choose Speciality

EXPLORE!

LOGIN

By signing up or signing in to eMediNexus, you consent to eMediNexus collecting and using your personal data in accordance with our Privacy Policy. We are committed to safeguarding your information and ensuring the highest standards of data protection. Your trust and privacy are of utmost importance to us.

AstraZeneca seeks approval from U.S. regulators for antibody cocktail to prevent COVID-19

  592 Views

eMediNexus    06 October 2021

AstraZeneca has sought emergency approval from U.S. regulators for its antibody cocktail for protection against COVID-19.

AstraZeneca′s biotech compound, called AZD7442, contains lab-developed antibodies that can persist in the body for months to check the virus in there is an infection. The treatment, created to last for several months to about one year, could provide protection to those who do not have a strong immune response to COVID-19 vaccines, which could be due to, chemotherapy or drugs given after organ transplants, among other causes.

The drug, which is administered in two injections, could also act as a supplement to vaccination course for individuals who need to boost their protection further, stated the company… (Reuters, October 5, 2021)

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.